Several methods are introduced to increase the half-life of GLP-1 including: (i) modifying peptides to make them resistant to cleavage by DPP-4, such as exenatide twice daily and lixisenatide, (ii) attaching free fatty acid side chains to liraglutide and semaglutide, which enhances their binding to plasma albumin thereby preventing renal filtration of GLP-1 and prolonging their action in vivo [36, 37], (iii) conjugation of albumin or the Fc fragment of IgG to GLP-1 molecule is used in albiglutide and dulaglutide [37, 38], (iv) development of modified nanoparticles for the controlled release of exenatide-LAR (long-acting release) that provide prolonged release of the peptide [39], and finally, (v) chemical permeation enhancers such as sodium salcaprozate (SNAC) could be utilized to overcome the low permeability and high enzymatic degradation of the gastrointestinal tract of GLP-1 analog that is administrated orally such as semaglutide [40]

The degree of autoproteolytic processing correlates with the severity of mitochondrial fragmentation as SnCE1 Y212A was the most efficiently processed SnCE1 variant
Timing matters: MOTS-c is most effective during fasted states or pre-training windows, while 5-amino-1MQ maintains NAD+ elevation when dosed consistently daily
The metabolic enhancement from glucagon activation combined with appetite suppression from GLP-1 and potential fat distribution benefits from GIP creates multiple layers of weight regulation support
Medications can be tools, but they do not replace the basics of daily health routines